NewAmsterdam Pharma N.V.
(NAMSW)
undefined
undefined%
At close: undefined
13.02
-3.41%
After-hours Dec 13, 2024, 03:03 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Cash & Equivalents | 340.45M | 438.52M | 53.09M | 7.86M |
Short-Term Investments | - | - | - | - |
Long-Term Investments | - | - | 718.35K | 112.79M |
Other Long-Term Assets | 35.00K | 146.00K | -353 | -112.79M |
Receivables | 1.88M | 2.07M | 4.86M | - |
Inventory | - | 21.50K | -735 | - |
Other Current Assets | 4.46M | 8.18M | 7.47M | 1.67M |
Total Current Assets | 346.79M | 448.13M | 58.87M | 9.22M |
Property-Plant & Equipment | 101.00K | 144.00K | 190.00K | 12.00K |
Goodwill & Intangibles | 170.00K | 83.16M | - | - |
Total Long-Term Assets | 306.00K | 83.45M | 908.00K | 12.00K |
Total Assets | 347.10M | 531.58M | 59.78M | 9.23M |
Account Payables | 16.92M | 11.85M | 7.04M | 487.06K |
Deferred Revenue | 8.94M | 13.01M | 3.61M | - |
Short-Term Debt | 60.00K | 66.00K | 60.01K | 11.65M |
Other Current Liabilities | 23.97M | 9.67M | 1.31M | 670.94K |
Total Current Liabilities | 49.90M | 35.46M | 9.88M | 12.81M |
Long-Term Debt | - | 60.00K | 125.68K | - |
Other Long-Term Liabilities | 7.79M | 6.75M | -14.68K | - |
Total Long-Term Liabilities | 8.81M | 11.60M | 111.00K | 9.95M |
Total Liabilities | 58.70M | 47.06M | 9.99M | 12.81M |
Total Debt | 60.00K | 118.00K | 164.00K | 11.65M |
Common Stock | 10.17M | 599.19M | 83.88M | 2.50M |
Retained Earnings | -316.97M | -119.36M | -34.68M | -6.08M |
Comprehensive Income | 4.42M | 4.69M | 591.00K | - |
Shareholders Equity | 288.39M | 484.52M | 49.79M | -3.58M |
Total Investments | -31.08M | - | 718.35K | 112.79M |